Sakshi Agarwalla

Sakshi Agarwalla

Sakshi Agarwalla has more than 8 years of experience in writing equity research reports and preparing financial models for companies across various industries.

She also has exposure in making industry presentations, writing newsletters, and financial articles.

In her last two years, she was assisting her Fund manager in executing trades, preparing weekly, monthly NAVs and writing newsletters.
She has a postgraduate degree in finance and has completed CFA.

Recent Articles

Is Canopy Growth a Buy After its Announcement to Cut Costs?

CGC stock has delivered losses for two years despite cannabis legalization on Canada. The company will not generate profits soon.

Has Clover Health Finally Bottomed Out?

Clover is delivering improved operational results. Management's better than expected guidance lends positive outlook to CLOV stock.

3 Onshore Stocks Set to Outperform in 2022

These onshore drilling companies should benefit given their technologically advanced rig base and standing in the industry.

3 Dividend Stocks for Value Investors Seeking Regular Income

The list includes high dividend paying stocks that are growing at a steady rate, suitable for income-seeking investors.

Cassava Sciences Is a Worthwhile Bet to Consider

FDA approval for Simufilam and successful trials of a new blood test to detect Alzheimer's disease could help propel SAVA stock back up.